MedPath

The influence of topical appliqued capsaicin on the intensity and quality of chronic neuropathic pai

Conditions
europathic painQuality of life
G62.9
Polyneuropathy, unspecified
Registration Number
DRKS00011198
Lead Sponsor
Zentrum für Schmerztherapie und Palliativmedizin Heidelberg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
45
Inclusion Criteria

The persons who are included in the trial should have 18 years. These should be treated at the university hospital of Heidelberg since 2010 with the Qutenza-plaster for the reason of chronic neuropathic pain.

Exclusion Criteria

It doesn´t exist an exclusion criteria.

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Intensity of the pain bevor and after the treatment with the Qutenza-plaster. A positive effect can be detect when the pain scale (numeric rating scale) is reduced by =3 points.<br>The process data is collected in the files of patients and a questionnaire.
Secondary Outcome Measures
NameTimeMethod
-change of quality of pain<br>-quality of life<br>-diagnosis of the pain<br>-number of treatments with the patch<br>-quality of sleep<br>-side effects<br>-non-medicinal therapy (additional)<br>-change of medication<br>-intensity of current pain<br><br>The survey will be realized with a individually developed questionnaire. This one will be hand over to all patients at the end of October 2016 and includes questions about one to six treatments.
© Copyright 2025. All Rights Reserved by MedPath